Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-1-9
pubmed:abstractText
Interferon (IFN)-alpha is widely used in the treatment of mycosis fungoides (MF) and when used in combination with photochemotherapy (psoralen plus ultraviolet A, PUVA) both improved response and duration of complete remission have been reported. However, in spite of encouraging results of the initial studies, currently there is no information available on specific prognostic factors enabling prediction of patients' resistance to PUVA +/- IFN-alpha treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1365-2133
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
160
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
92-102
pubmed:meshHeading
pubmed-meshheading:18945306-Adolescent, pubmed-meshheading:18945306-Adult, pubmed-meshheading:18945306-Aged, pubmed-meshheading:18945306-Combined Modality Therapy, pubmed-meshheading:18945306-Drug Resistance, Neoplasm, pubmed-meshheading:18945306-Female, pubmed-meshheading:18945306-Gene Expression Profiling, pubmed-meshheading:18945306-Humans, pubmed-meshheading:18945306-Immunohistochemistry, pubmed-meshheading:18945306-Interferon-alpha, pubmed-meshheading:18945306-Male, pubmed-meshheading:18945306-Middle Aged, pubmed-meshheading:18945306-Mycosis Fungoides, pubmed-meshheading:18945306-NF-kappa B, pubmed-meshheading:18945306-PUVA Therapy, pubmed-meshheading:18945306-Receptors, Antigen, T-Cell, pubmed-meshheading:18945306-Signal Transduction, pubmed-meshheading:18945306-Skin Neoplasms, pubmed-meshheading:18945306-Treatment Outcome, pubmed-meshheading:18945306-Young Adult
pubmed:year
2009
pubmed:articleTitle
Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
pubmed:affiliation
Molecular Pathology Program, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't